Stay updated on Nivolumab Plus Cabozantinib in Non-Clear Cell RCC Clinical Trial

Sign up to get notified when there's something new on the Nivolumab Plus Cabozantinib in Non-Clear Cell RCC Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Nivolumab Plus Cabozantinib in Non-Clear Cell RCC Clinical Trial page

  1. Check
    5 days ago
    No Change Detected
  2. Check
    12 days ago
    No Change Detected
  3. Check
    20 days ago
    Change Detected
    Summary
    The page footer was updated to reflect a newer system revision (from v3.5.2 to v3.5.3), without changing the displayed study information.
    Difference
    0.0%
    Check dated 2026-04-25T17:52:30.000Z thumbnail image
  4. Check
    27 days ago
    Change Detected
    Summary
    Revision updated from v3.5.0 to v3.5.2.
    Difference
    0.0%
    Check dated 2026-04-18T13:14:46.000Z thumbnail image
  5. Check
    56 days ago
    Change Detected
    Summary
    Revision metadata updated to show v3.5.0, replacing the older v3.4.3.
    Difference
    0.0%
    Check dated 2026-03-20T19:49:08.000Z thumbnail image
  6. Check
    70 days ago
    Change Detected
    Summary
    The revision stamp in the page footer was updated from v3.4.2 to v3.4.3.
    Difference
    0.0%
    Check dated 2026-03-06T16:40:54.000Z thumbnail image
  7. Check
    91 days ago
    Change Detected
    Summary
    Revision label updated from v3.4.1 to v3.4.2. No changes to study data, eligibility criteria, or navigation.
    Difference
    0.0%
    Check dated 2026-02-12T23:07:32.000Z thumbnail image
  8. Check
    99 days ago
    Change Detected
    Summary
    Revision: v3.4.1 was added and Revision: v3.4.0 was removed, which are minor UI metadata changes. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.0%
    Check dated 2026-02-05T12:19:45.000Z thumbnail image

Stay in the know with updates to Nivolumab Plus Cabozantinib in Non-Clear Cell RCC Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Nivolumab Plus Cabozantinib in Non-Clear Cell RCC Clinical Trial page.